Topics › Health Sciences › Medicine › Pulmonary and Respiratory Medicine
Prostate Cancer Treatment and Research Sign in to save
Papers per year
Papers 71
Open in paper search →-
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial2020 European Urology article Medicine Prostate Cancer Treatment and Research Open access cited by 1 patent
Andrew J. Armstrong, Ping Lin, Bertrand F. TOMBAL, Fred Saad, Celestia S. Higano, Anthony Michael Joshua, +4 more
170citations -
PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients2024 European Journal of Radiology article Medicine Prostate Cancer Treatment and Research Open access
Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Saskia A. C. Luelmo, Jelle J. Goeman, Frits Smit, Tom van der Hulle, +1 more
22citations -
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study2021 International Journal of Urology article Medicine Prostate Cancer Treatment and Research Open access
Taro Iguchi, Go Kimura, Satoshi Fukasawa, Hiroyoshi Suzuki, Hiroji Uemura, Kazuo Nishimura, +9 more
22citations -
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium2024 Journal of Translational Medicine article Medicine Prostate Cancer Treatment and Research Open access
Sherif Mehralivand, Christian Thomas, Martin Puhr, Frank Claessens, Arjanneke F. van de Merbel, Anna Dubrovska, +4 more
19citations -
A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE2021 International Journal of Cancer article Medicine Prostate Cancer Treatment and Research Open access
Heather Ann Payne, Angus Robinson, Bernard Rappe, Serena Hilman, Ugo De Giorgi, Steven Joniau, +13 more
18citations -
Phase 1b study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTEimmune-oncology therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC).2021 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Treatment and Research
Rahul Raj Aggarwal, Ana Maria Aparicio, Axel Heidenreich, Shahneen Kaur Sandhu, Yiran Zhang, Mark Salvati, +1 more
14citations -
Patient-derived xenografts and organoids model therapy response in prostate cancer2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Prostate Cancer Treatment and Research Open access
Sofia Karkampouna, Federico La Manna, Maria Rosaria De Filippo, Mirjam Kiener, Marta De Menna, Eugenio Zoni, +18 more
13citations -
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology2025 International Journal of Molecular Sciences article Medicine Prostate Cancer Treatment and Research Open access
Yasra Fatima, Kirubel Nigusu Jobre, Enrique Gómez‐Gómez, Bartosz Małkiewicz, Antonia Vlahou, Marika Mokou, +3 more
10citations
Most active Aachen authors
-
Matthias Saar 2,300 citations overall10 papers
-
Tom van der Hulle 3,947 citations overall7 papers
-
Lioe‐Fee de Geus‐Oei 11,683 citations overall5 papers
-
Gabri van der Pluijm 9,074 citations overall5 papers
-
Linda Heijmen 544 citations overall5 papers
-
Fleur Kleiburg 138 citations overall5 papers
-
Felix Manuel Mottaghy 33,749 citations overall4 papers
-
Ralf Weiskirchen 30,612 citations overall4 papers
-
Geertje van der Horst 4,249 citations overall4 papers
-
Frits Smit 662 citations overall4 papers
-
Jennifer Kranz 4,315 citations overall3 papers
-
Federico La Manna 1,152 citations overall3 papers
-
Sarah K. Schröder 570 citations overall3 papers
-
Arjanneke F. van de Merbel 374 citations overall3 papers
-
Hans A. J. Gelderblom 55,175 citations overall2 papers